CSIMarket
 


Quidel Corporation  (QDEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

QDEL's Revenue Growth by Quarter and Year

Quidel's Revenue results by quarter and year




QDEL Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 809.20 152.18 132.59
III Quarter September - 476.06 126.49 117.40
II Quarter June - 201.75 108.25 103.16
I Quarter March 375.34 174.65 147.97 169.14
FY   375.34 1,661.66 534.89 522.29



QDEL Revenue first quarter 2021 Y/Y Growth Comment
Quidel Corporation achieved in the first quarter, above Company average Revenue surge of 114.91% year on year, to $ 375.34 millions.

Looking into first quarter results within Biotechnology & Drugs industry 24 other companies have achieved higher Revenue growth. While Quidel Corporation' s Revenue doubling of 114.91% ranks overall at the positon no. 254 in the first quarter.




QDEL Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 431.74 % 14.77 % 15.41 %
III Quarter September - 276.36 % 7.74 % 130.69 %
II Quarter June - 86.37 % 4.93 % 169.56 %
I Quarter March 114.91 % 18.03 % -12.52 % 129.53 %
FY   - 210.65 % 2.41 % 88.05 %

Financial Statements
Quidel's first quarter 2021 Revenue $ 375.34 millions QDEL's Income Statement
Quidel's first quarter 2020 Revenue $ 174.65 millions Quarterly QDEL's Income Statement
New: More QDEL's historic Revenue Growth >>


QDEL Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 69.98 % 20.31 % 12.94 %
III Quarter September - 135.97 % 16.85 % 13.8 %
II Quarter June - 15.52 % -26.84 % -39.01 %
I Quarter March -53.62 % 14.77 % 11.6 % 47.22 %
FY (Year on Year)   - 210.65 % 2.41 % 88.05 %




Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #25
Healthcare Sector #74
Overall #254

Revenue Y/Y Growth Statistics
High Average Low
431.75 % 54.08 % -24.71 %
(Dec 31 2020)   (Mar 31 2014)
Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #25
Healthcare Sector #74
Overall #254
Revenue Y/Y Growth Statistics
High Average Low
431.75 % 54.08 % -24.71 %
(Dec 31 2020)   (Mar 31 2014)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Quidel's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
135.96 % 16.33 % -53.62 %
(Sep 30 2020)  


QDEL's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2021 Quidel Corporation reported fall in Revenue from the previous quarter by -53.62% to $ 375.34 millions, from $ 809.20 millions released in the previous reporting period.

Those periodic circumstance were not able to recover the I. Quarter for the Quidel Corporation, Atharv Sengupta , Biotechnology & Drugs industry researcher located in Bangalore wrote, he cited little pessimism conserning Quidel's perspective, he detected further headwinds down the road for the Biotechnology & Drugs's company and continued that average sequential Revenue growth is at 16.33% for the Biotechnology & Drugs's company.

Within Biotechnology & Drugs industry 102 other companies have achieved higher Revenue quarter on quarter growth. While Quidel's Revenue growth quarter on quarter, overall rank is 3419.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #103
Healthcare Sector #484
Overall #3419
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #103
Healthcare Sector #484
Overall #3419
Revenue Q/Q Growth Statistics
High Average Low
135.96 % 16.33 % -53.62 %
(Sep 30 2020)  


QDEL's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2021 Quidel Corporation realized fall in Revenue sequentially by -53.62% to $ 375.34 millions, from $ 809.20 millions declared in the previous reporting period.

Although cyclical influence commonly elevate I. Quarter 2021 performance, this plainly could not be enough to recover QDEL's I. Quarter achievement, Atharv Sengupta , Biotechnology & Drugs industry researcher located in Bangalore pointed out.

Within Biotechnology & Drugs industry 102 other companies have achieved higher Revenue quarter on quarter growth. While Quidel's Revenue growth quarter on quarter, overall rank is 3419.


Quidel's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Revenue 12 Months Ending $ 1,862.35 $ 1,661.67 $ 1,004.64 $ 655.08 $ 561.58
Y / Y Revenue Growth (TTM) 231.63 % 210.66 % 94.96 % 29.41 % 12.07 %
Year on Year Revenue Growth Overall Ranking # 114 # 84 # 25 # 73 # 362
Seqeuential Revenue Change (TTM) 12.08 % 65.4 % 53.36 % 16.65 % 4.99 %
Seq. Revenue Growth (TTM) Overall Ranking # 562 # 146 # 73 # 169 # 232




Cumulative Revenue growth Comment
With 231.63% annual Revenue growth, Quidel Corporation would report a record annual Revenue surge if the fiscal year would end on Mar 31 2021.

In the Healthcare sector 45 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 84 to 114.

Revenue TTM Q/Q Growth Statistics
High Average Low
65.4 %
9.21 %
-16.13 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 29
Healthcare Sector # 46
Overall # 114

Revenue TTM Y/Y Growth Statistics
High Average Low
231.63 %
39.83 %
-11.79 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 106
S&P 500 # 562
Cumulative Revenue growth Comment
With 231.63% annual Revenue growth, Quidel Corporation would report a record annual Revenue surge if the fiscal year would end on Mar 31 2021.

In the Healthcare sector 45 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 84 to 114.

Revenue TTM Q/Q Growth Statistics
High Average Low
65.4 %
9.21 %
-16.13 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 29
Healthcare Sector # 46
Overall # 114

Revenue TTM Y/Y Growth Statistics
High Average Low
231.63 %
39.83 %
-11.79 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 106
S&P 500 # 562




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
QDEL's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for QDEL's Competitors
Revenue Growth for Quidel's Suppliers
Revenue Growth for QDEL's Customers

You may also want to know
QDEL's Annual Growth Rates QDEL's Profitability Ratios QDEL's Asset Turnover Ratio QDEL's Dividend Growth
QDEL's Roe QDEL's Valuation Ratios QDEL's Financial Strength Ratios QDEL's Dividend Payout Ratio
QDEL's Roa QDEL's Inventory Turnover Ratio QDEL's Growth Rates QDEL's Dividend Comparisons



Companies with similar Revenue surge for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2021
Alpine Immune Sciences Inc 199.45%$ 199.450 millions
Ocular Therapeutix Inc 181.41%$ 181.411 millions
Bionano Genomics Inc 178.87%$ 178.873 millions
Global Blood Therapeutics Inc 176.55%$ 176.548 millions
Ultragenyx Pharmaceutical Inc 173.75%$ 173.748 millions
T2 Biosystems Inc 173.32%$ 173.320 millions
Harpoon Therapeutics Inc 173.19%$ 173.188 millions
Geron Corp163.46%$ 163.462 millions
Opko Health Inc 157.80%$ 157.803 millions
Adapthealth Corp 151.84%$ 151.839 millions
Teladoc Health inc 150.93%$ 150.928 millions
Blueprint Medicines Corporation145.99%$ 145.993 millions
Aveo Pharmaceuticals Inc 144.90%$ 144.898 millions
Gtx Corp138.35%$ 138.348 millions
Vyne Therapeutics Inc 135.37%$ 135.371 millions
Precision Biosciences Inc133.62%$ 133.624 millions
Ontrak Inc 132.79%$ 132.793 millions
Myomo Inc 131.76%$ 131.761 millions
Sangui Biotech International Inc129.96%$ 129.964 millions
Lannett Co Inc124.78%$ 124.776 millions
Pressure Biosciences Inc120.53%$ 120.533 millions
Denali Therapeutics Inc 119.84%$ 119.839 millions
Quidel Corporation114.90%$ 114.905 millions
Shockwave Medical Inc 109.91%$ 109.910 millions
Paratek Pharmaceuticals Inc 107.41%$ 107.412 millions
Sutro Biopharma Inc 104.98%$ 104.978 millions
Hologic Inc103.36%$ 103.359 millions
Syros Pharmaceuticals inc 102.90%$ 102.900 millions
Sangamo Therapeutics Inc 100.98%$ 100.979 millions
Heska Corporation97.37%$ 97.374 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IVFH's Profile

Stock Price

IVFH's Financials

Business Description

Fundamentals

Charts & Quotes

IVFH's News

Suppliers

IVFH's Competitors

Customers & Markets

Economic Indicators

IVFH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071